Wolfe Peter

Wolfe Peter is listed in filings as Chief Financial Officer at ZyVersa Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jul 15, 2025, including 1 public disclosure. Recent filings connect the profile to ZyVersa Therapeutics, Inc. (ZVSA). The current snapshot covers public activity from Jul 15, 2025. Reported amounts are shown as $35.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.